Panakeia

We’re in Amsterdam for this year’s HLTH Europe conference! Don’t miss our CEO & Founder Pahini Pandya speaking about Panakeia’s mission to develop novel AI-driven approaches to deliver faster, earlier diagnosis and personalised treatment as well as our journey through the Texas Medical Center Innovation program. We’ll be joined by fellow innovative European companies in what promises to be a thought provoking discussion on US market expansion. Panel discussion Session title: “Texas Medical Center Innovation: Startup showcase” Thursday 20th June 2024 11:30 AM – 12:10 PM CEST Startup Stage See the full agenda here: https://lnkd.in/dPU55jE8

As we return from an exciting trade mission to Boston and #ASCO24, we have many things to be grateful for. Our CEO & Founder Pahini Pandya took part in an action-packed trade mission organised by London & Partners and led by Rikesh Patel. We met familiar and new faces of the Boston biotech scene and spent time with fellow innovators from other London-based life sciences companies. We also attended the American Society of Clinical Oncology (ASCO) 2024 Annual meeting, where we had the opportunity to present results of our PANProfiler Breast UKCA and CE-marked solution blind validation study conducted with our collaborators at the Leeds Teaching Hospitals NHS Trust  and to discuss the capabilities of our AI-enabled multiomics platform with like-minded scientists, physicians, investors and innovators from across the globe. Following our recent travels, we are even more excited to continue to develop novel AI-driven approaches to deliver faster, earlier diagnosis and personalised treatment.

We are on the ground at American Society of Clinical Oncology (ASCO) 2024 Annual meeting taking place in Chicago,IL.   Our CEO and founder Pahini Pandya will be presenting key findings from a blind validation study of our PANProfiler Breast UKCA and CE-marked solution for HER2, ER, and PR biomarker profiling from H&E-stained breast cancer specimens.   Drop by our poster or get in touch if you are interested in meeting with Pahini to discuss our results and how our deep learning approach can deliver faster, more accessible molecular testing, leading to earlier diagnosis and personalised treatment, ultimately improving patient outcomes.   See the full details here: https://lnkd.in/gffqsErj #ASCO24 #oncology #precisionmedicine #diagnostics #multiomics

We have been shortlisted for the “Best Medical Technology” category of the Prix Galien UK awards, organised by the The Galien Foundation, for our PANProfiler Breast software application!   PANProfiler Breast offers ER, PR and Her2 biomarker results entirely digitally, in minutes. The first in of a suite of solutions, PANProfiler Breast enables faster, more accessible molecular testing, leading to earlier diagnosis and personalised treatment plans, ultimately improving patients’ lives.   We are honoured to be nominated for such a prestigious award, the "Oscars for Innovators", amongst some of the most innovative medical technology applications. Good luck to all the nominees!   To find out more about the awards visit:

Our CEO & Founder, Pahini Pandya's talk at the Texas Medical Center Innovation Demo Day has been included in King's Entrepreneurship Institute's first #EICommunitySpotlight of 2024! We highly appreciate this recognition and our continued relationship with King's Entrepreneurship Institute.

"One of my biggest takeaways from the panel today was that AI is here, and the changes in care pathways due to AI are actually happening today." Watch as Dr Pahini Pandya, Panakeia, talks at our #AIDATA23 event👇 https://lnkd.in/d6VdASZn

📣 Panakeia's incredible team will be presenting latest findings at #SABCS23 showcasing robust and accurate ER/PR status predictions directly from H&E-stained tissue images in patients with breast cancer. Read the details in our: 📜 Poster Presentation (PO3-07-05): Multi-site validation of a deep learning solution for ER/PR profiling of breast cancer from H&E-stained pathology slides. Date: Thursday, December 7, 2023 Time: 12:00 PM - 2:00 PM CT (Poster Session 3) Location: Hall 2-3 Our mission is to transform clinical workflows bringing accelerated benefits to patients and improve treatment outcomes. Contact [ishaan@panakeia.ai] to secure a on-site meeting with our CEO & Founder, Pahini Pandya. #cancerresearch #breastcancer #earlydetection #multiomics #PrecisionMedicine

Our CEO & Founder, Pahini Pandya recently delivered a talk showcasing Panakeia’s AI-driven solutions capable of transforming  #precisionmedicine through next generation #cancerdiagnostics at the Texas Medical Center Innovation Demo Day! As a part of the inaugural Bio-Bridge program at Texas Medical Center Innovation, led by Innovate UK,  the Accelerator program offered an incredible opportunity to gain invaluable insights and build key relationships with health systems within Texas. Panakeia was privileged to be selected alongside a cohort of innovative British companies delivering groundbreaking research and technology in the field of healthcare. (Shout-out to C the Signs | Surgery Hero | PEP Health | ScubaTx Limited | NuVision Biotherapies Ltd | Somnus Scientific | CALON CARDIO-TECHNOLOGY LTD | PreciousMD ltd and more) We express our deepest gratitude to the team at Texas Medical Center Innovation and Innovate UK for this incredible opportunity and their immense support - Jon Hazell | Ian Fletcher | Chris Sawyer | Emily Reiser | Zaffer Syed | Saniya Mansuri | Devin Dunn | John (JR) Reale | Thomas Luby | Elliana Tuttle | Richard Hyde | Autumn Waska, MBA, MCTM | Joseph Valdez | Farzad Soleimani, MD, MBA, FAAEM. And a special thank you to the Rt Hon Michelle Donelan MP, Secretary of State for Science, Innovation, and Technology, for joining us in Houston. Furthermore, Panakeia was also honoured to be named as one of the Most Promising companies at the Texas Life Sciences Forum at Rice University. As delighted we are to receive this recognition, our journey is only just beginning. Let’s make precision medicine accessible to patients and doctors all over the world! #TMCiAccelerator #HealthTech #Innovation #AIHealthcare #StartupJourney #BioInnovationInstitute #TLSF

Join our Founder & CEO, Pahini Pandya at @HealthAIData in London today to learn about how Panakeia leverages AI to help reduce turn-around times and support faster cancer diagnosis and treatment within the NHS. 🗓️ Date: 30th October 2023 ⌚️ Time: 12:45 - 13:30 📍 Location: AI and Data Showcase, Business Design Centre, 52 Upper St, London N1 0QH More information here: https://lnkd.in/d2tWrWJG #AIDATA23 #DigitalHealth #OncologyInnovation #DrugDevelopment #PrecisionMedicine #MultiOmics

We are at #ESMO23 to present the results of our multi-site validation evaluation of our UKCA-marked PANProfiler Breast (HER2 Negative). Learn how H&E-based biomarker profiling using deep learning can help accelerate clinical workflows to improve patient experience and outcomes. Come see us at: Poster Presentation 1226P: Multi-site validation of a deep learning solution for HER2 profiling of breast cancer from H&E-stained pathology slides Pahini Pandya Salim Arslan #OncologyInnovation